COUNTERMEASURES INC. (CMI) is a virtual manufacturing company that has a contract to supply 500 doses of recombinant anthrax vaccine to the US Department of Defense (DOD). The Government will test the vaccine in phase I clinical trial involving military and civilian personnel. The DOD will be the Sponsor and holder of the IND under which the trial will be performed). Since it has no manufacturing facility of its own, CMI subcontracted with MEGATECH Inc. (MTI), a contract manufacturing Organization (CMO) that owns a current Good Manufacturing Practice (CGMP) – compliant manufacturing facility, to manufacture and deliver the vaccines to the Repository at the Trials-R-US (TRU) clinic with whom (DOD) has negotiated to carry out the phase I clinical trial. As the staff at TRU was receiving the vaccines that came in three pallets, they observed that one corner of one pallet had been bashed in and as they unwrapped the outside coverings, they discovered that many of the vials had been crushed and their contents spilled. The two intact pallets were moved into a walk-in temperature-controlled holding area while the third (damaged) was transferred to a separate walk-in temperature-controlled area. The vaccine excipient included a rich medium with a broad buffering capacity requiring a storage temperature of 2-4oC. Four days later, the Quality control manager at TRU who had been away on a trip went into the walk-in area where the damaged pallet was being held to complete the paperwork he would need to prepare his report to CMI. He immediately noted that it was quite warm in the room, obviously warmer than 10oC.
ASSIGNMENT: develop a regulatory response to this scenario. You should develop a narrative anchored around the above scenario to illustrate and give context to their response. Your assignment is to prepare a report that addresses the issues assigned to FDA Inspector as follows:
Group IV FDA Inspector
As a Regulatory Agent:
(a) Would you expect these incidents to be documented? If so, what type of documentation would you expect?
(b)What action(s) would you demand on the part of DOD in order to allow the clinical evaluation of this Anthrax vaccine to proceed?
(c) What laws and/or regulations would you use to support your demand(s) in (b)?
Provide your response as a report that includes citations of laws, regulations, and guidance/Points to Consider documents using the APA reference style.
Note:
-
The Anthrax vaccine was filled with excipients that provide buffering capacity but also support microbial growth
-
Assume that the FDA Inspector is on inspection at MGI several months after the incidents described with the vaccine shipment.
What Students Are Saying About Us
.......... Customer ID: 12*** | Rating: ⭐⭐⭐⭐⭐"Honestly, I was afraid to send my paper to you, but you proved you are a trustworthy service. My essay was done in less than a day, and I received a brilliant piece. I didn’t even believe it was my essay at first 🙂 Great job, thank you!"
.......... Customer ID: 11***| Rating: ⭐⭐⭐⭐⭐
"This company is the best there is. They saved me so many times, I cannot even keep count. Now I recommend it to all my friends, and none of them have complained about it. The writers here are excellent."
"Order a custom Paper on Similar Assignment at essayfount.com! No Plagiarism! Enjoy 20% Discount!"
